| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| R&D Expense | $133K | — |
| SG&A Expense | $54.7M | +370.3% |
| Operating Income | -$67.8M | -284.7% |
| Interest Expense | $6K | +20.0% |
| Pre-tax Income | -$66.7M | -246.5% |
| Income Tax | $0 | — |
| Net Income | -$66.7M | -246.5% |
| EPS (Basic) | -$1.63 | -191.1% |
| EPS (Diluted) | -$1.63 |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.1M | -23.9% |
| Current Assets | $32.6M | -20.5% |
| Total Assets | $70.9M | +9.7% |
| Current Liabilities | $7.4M | +337.6% |
| Long-term Debt | $148K | +59.9% |
| Total Liabilities | $8.2M | +260.7% |
| Stockholders' Equity | $62.7M | +0.5% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.6M | -162.8% |
| Capital Expenditures | $1.2M | +3028.2% |
| Investing Cash Flow | -$11.4M | +12.0% |
| Financing Cash Flow | $30.6M | -18.9% |
| Free Cash Flow | -$29.8M | -173.0% |
| -191.1% |